Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N Wendland
Mutation Analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 Patients With MDS or Secondary AML
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Donor HSCs With a Preexisting ASXL1-mutation Led to the Development of FLT3-ITD Positive AML in the Donor and FLT3-ITD Negative AML in the Recipient After Unrelated Transplant
Bone Marrow Transplantation
Transplantation
Hematology
NOX-driven ROS Formation in Cell Transformation of FLT3-ITD-positive AML
Experimental Hematology
Cancer Research
Genetics
Hematology
Molecular Biology
Cell Biology
Association Between Increased Mutation Rates in DNMT3Α and FLT3‑ITD and Poor Prognosis of Patients With Acute Myeloid Leukemia
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Adult Acute Myeloid Leukemia With Trisomy 11 as the Sole Abnormality Is Characterized by the Presence of Five Distinct Gene Mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Physicians Poster Session: Acute Leukemia and Secondary AML/MDS
Bone Marrow Transplantation
Transplantation
Hematology
Identification of FLT3 and NPM1 Mutations in Patients With Acute Myeloid Leukaemia
Asian Pacific Journal of Cancer Prevention
Dnmt3a Deletion Cooperates With the Flt3/Itd Mutation to Drive Leukemogenesis in a Murine Model
Oncotarget
Oncology
FLT3-ITD Compared With DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult AML Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Turkish Journal of Haematology
Hematology
Glasdegib in Combination With Cytarabine and Daunorubicin in Patients With AML or High-Risk MDS: Phase 2 Study Results
American Journal of Hematology
Hematology
